ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meeting Abstracts
    • All Meetings
    • ACR Convergence 2026
    • PRSYM 2026
    • ACR Convergence 2025
    • Download Abstract Supplements
  • Keyword Index
  • My Favorites
    • View & print my favorites
  • Search

Home » Meeting Abstracts » ACR/ARHP Annual Meeting 2014

Abstract Number: 2409

Omega-3 Fatty Acids and Mediterranean Diet As Complimentary Therapies for Rheumatoid Arthritis

Ana Carolina Araújo1, Maria Francisca Moraes-Fontes1, Lèlita Santos2 and Nuno Riso1, 1Serviço de Medicina 2, Hospital de Curry Cabral, Centro Hospitalar Lisboa Central, Lisbon, Portugal, 2Serviço de Medicina Interna, Centro Hospitalar Universitário de Coimbra, Coimbra, Portugal

Share on X (Twitter) Share on Facebook Share on LinkedIn Share on Email
Print

Meeting: ACR/ARHP Annual Meeting 2014

Keywords: Dietary supplements and rheumatoid arthritis, treatment

Session Information

Title: Rheumatoid Arthritis - Clinical Aspects (ACR): Impact of Various Interventions and Therapeutic Approaches

Session Type: Abstract Submissions (ACR)

Background/Purpose

Rheumatoid arthritis (RA) is a chronic inflammatory disease affecting the synovial joints, often with a progressive and destructive course, leading to disability. Nowadays, there are several drugs available to treat this condition. However, in some patients the disease can be quite difficult to manage, due to refractoriness and expense of therapy. Complimentary therapies to manage RA may contribute to this unmet need. The anti-inflammatory effect of the Mediterranean diet (MedDiet) has been increasingly recognized in the last forty years together with the anti-inflammatory properties of omega-3 fatty acids (n-3 FA) [1,2].

This study aimed to evaluate the effects of n-3 FA supplements and MedDiet upon disease activity and laboratory measures of a cohort of RA patients.

Methods

This is a prospective randomized controlled trial including 37 RA patients (fulfilling ACR 1987 classification criteria). Patients were assigned to n-3 FA supplements (n=11) or MedDiet (n=8) and compared to a control group (n=15), during a 6 month follow-up period. Demographic characteristics, number of tender and swollen joints, global health status, ESR, CRP, and DAS-28 were obtained before and after the intervention. The analysis of dietary intake was performed with a semi-quantitative food frequency questionnaire. Patients were further stratified according to biological therapy. The statistical analysis was performed by Wilcoxon and Kruskal-Wallis tests with a significance level of 0,05.

Results

A significant reduction in ESR was noted after 6 months of n-3 FA but there was no significant variation in the remaining measures after 6 months, independently of the study group and the ongoing therapy for RA. However, a trend towards a reduction in DAS-28 and VAS was noted (table 1).

Table 1 – Evaluated parameters at the beginning and after 6 months of intervention.

 

n-3 FA

MedDiet

Control Group

p

Parameter

Beginning

6 months

n

p

Beginning

6 months

n

p

Beginning

6 months

n

p

ESR

32,18 ± 19,42

19,64 ± 13,27

11

0,01

21,75 ± 17,32

24,75 ± 13,72

8

0,58

28,00 ± 21,03

22,13 ± 12,02

15

0,12

> 0,05

DAS-28

3,65 ± 1,26

3,41 ± 1,10

11

0,76

3,30 ± 1,02

3,53 ± 1,65

8

0,55

3,58 ± 0,91

3,94 ± 1,13

15

0,36

> 0,05

EVA GH

39,09 ± 26,16

38,18 ± 29,17

11

0,84

46,25 ± 17,68

43,75 ± 22,80

8

0,94

46,67 ± 26,10

51,00 ± 28,55

15

0,36

> 0,05

Tender Joints

3,54 ± 6,29

3,82 ± 5,51

11

0,73

3,00 ± 5,24

4,12 ± 5,03

8

0,13

2,33 ± 3,27

4,40 ± 5,18

15

0,10

> 0,05

Swollen Joints

1,45 ± 2,50

1,00 ± 1,79

11

0,44

0,25 ± 0,46

1,12 ± 1,88

8

0,25

0,53 ± 0,83

1,13 ± 2,06

15

0,25

> 0,05

CRP

0,14 ± 0,10

0,31 ± 0,40

6

1,00

0,45 ± 0,45

1,50 ± 2,35

5

0,13

0,82 ± 1,21

0,70 ± 0,41

9

0,16

> 0,05

Mean ± standard deviation; n,number of patients.

Conclusion

Omega-3 fatty acids supplements were associated with a reduction in the ESR after 6 months in accordance to other studies. The trend towards a reduction in DAS-28 observed in this study encourages the need for further studies in larger samples.

1. Serra-Majem, L., B. Roman, and R. Estruch, Scientific evidence of interventions using the Mediterranean diet: a systematic review. Nutr Rev, 2006. 64(2 Pt 2): p. S27-47.

2. Calder, P.C., Omega-3 polyunsaturated fatty acids and inflammatory processes: nutrition or pharmacology? Br J Clin Pharmacol, 2013. 75(3): p. 645-62.


Disclosure:

A. C. Araújo,
None;

M. F. Moraes-Fontes,
None;

L. Santos,
None;

N. Riso,
None.

ACR Meeting Abstracts - https://acrabstracts.org/abstract/omega-3-fatty-acids-and-mediterranean-diet-as-complimentary-therapies-for-rheumatoid-arthritis/

My Favorites

Save and print abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract (must have cookies enabled in browser). See saved favorites.

Abstract Policies

  • ACR Convergence Abstract Embargo Policies
  • ACR Convergence Abstract Permissions & Reprints
  • PRSYM Abstract Policies

ACR Convergence. Where Rheumatology Meets

ACR Convergence 2026

Join us November 6-11 in Orlando, Florida.
See Registration Information

  • Contact ACR
  • Privacy Policy
  • ACR Policies
  • Cookie Preferences

© Copyright 2026 American College of Rheumatology